Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Inv. presentation
CC transcript
Asset disposition
|
|
Cyclacel Pharmaceuticals, Inc. (CYCC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Rombotis Spiro George (President and CEO) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 57,600 shares
@ $0 |
|
| 02/02/2023 |
4
| Kirschbaum Mark (Chief Medical Officer) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 31,200 shares
@ $0 |
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Walker Karin L (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 15,822 shares
@ $0
Granted 31,645 options to buy
@ $1.11, valued at
$35.1k
|
|
| 06/16/2022 |
4
| Spiegel Robert J. (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 15,822 shares
@ $0
Granted 31,645 options to buy
@ $1.11, valued at
$35.1k
|
|
| 06/16/2022 |
4
| Sems Lloyd (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 15,822 shares
@ $0
Granted 31,645 options to buy
@ $1.11, valued at
$35.1k
|
|
| 06/16/2022 |
4
| SCHWARTZ BRIAN (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 15,822 shares
@ $0
Granted 31,645 options to buy
@ $1.11, valued at
$35.1k
|
|
| 06/16/2022 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 15,822 shares
@ $0
Granted 31,645 options to buy
@ $1.11, valued at
$35.1k
|
|
| 06/16/2022 |
4
| BARKER SAM L (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 15,822 shares
@ $0
Granted 31,645 options to buy
@ $1.11, valued at
$35.1k
|
|
| 12/15/2021 |
4
| Rombotis Spiro George (President and CEO) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 190,000 options to buy
@ $3.45, valued at
$655.5k
|
|
| 12/15/2021 |
4
| McBarron Paul (See Remarks) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $3.45, valued at
$345k
|
|
| 12/15/2021 |
4
| Kirschbaum Mark (Chief Medical Officer) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $3.45, valued at
$345k
|
|
| 12/02/2021 |
4
| BARKER SAM L (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Sold 12 shares
@ $3.5716, valued at
$42.9 |
|
| 11/22/2021 |
4
| Rombotis Spiro George (President and CEO) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Bought 4,000 shares
@ $4.5, valued at
$18k
|
|
| 08/25/2021 |
4
| BARKER SAM L (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Bought 1,000 shares
@ $5, valued at
$5k
|
|
| 06/17/2021 |
4
| Hradsky Gregory T. (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 2,374 shares
@ $0
Granted 4,748 options to buy
@ $6.69, valued at
$31.8k
|
|
| 06/17/2021 |
4
| Sems Lloyd (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 2,374 shares
@ $0
Granted 4,748 options to buy
@ $6.69, valued at
$31.8k
|
|
| 06/17/2021 |
4
| BARKER SAM L (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 2,374 shares
@ $0
Granted 4,748 options to buy
@ $6.69, valued at
$31.8k
|
|
| 06/17/2021 |
4
| Spiegel Robert J. (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 2,374 shares
@ $0
Granted 4,748 options to buy
@ $6.69, valued at
$31.8k
|
|
| 06/17/2021 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 2,374 shares
@ $0
Granted 4,748 options to buy
@ $6.69, valued at
$31.8k
|
|
| 06/17/2021 |
4
| SCHWARTZ BRIAN (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 2,374 shares
@ $0
Granted 1,187 shares
@ $0
Granted 4,748 options to buy
@ $6.69, valued at
$31.8k
Granted 2,374 options to buy
@ $6.69, valued at
$15.9k
|
|
| 06/17/2021 |
4
| Walker Karin L (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 2,374 shares
@ $0
Granted 1,187 shares
@ $0
Granted 4,748 options to buy
@ $6.69, valued at
$31.8k
Granted 2,374 options to buy
@ $6.69, valued at
$15.9k
|
|
| 12/21/2020 |
4
| SCHWARTZ BRIAN (Director) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 5,200 options to buy
@ $4.13, valued at
$21.5k
|
|
| 12/15/2020 |
4
| McBarron Paul (See Remarks) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 120,000 options to buy
@ $4.32, valued at
$518.4k
|
|
|
|
|